SCHEMBL11956943

SCHEMBL11956943

O=Cc1cn(CCO)c2c(N=O)cc(Cc3cccc(I)c3F)cc2c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13862197 0.89 ALDH1A1 (0.34) —
SCHEMBL11956950 0.87 ALDH1A1 (0.30) —
SCHEMBL13862191 0.85 — —
SCHEMBL13862195 0.80 ALDH1A1 (0.31) —
SCHEMBL11956460 0.77 — —
SCHEMBL12957421 0.77 ALDH1A1 (0.35) —
SCHEMBL13862214 0.76 ALDH1A1 (0.37) —
SCHEMBL11956461 0.76 METTL3 (0.34) —
SCHEMBL13862190 0.74 CFD (0.35) —
SCHEMBL13862196 0.74 ALDH1A1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232401-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2012-07-31 — — US disclosed
Send feedback